The Genetics Podcast

EP 214: Innovating large-scale and sustainable genomics with Slavé Petrovski of AstraZeneca

EP 213: Inside the science of hearing loss and gene therapy for deafness with Ellen Reisinger of the University of Tübingen

EP 212: A hub-and-spoke model for accelerating rare disease drug development with Ananth Sridhar and Sun-Gou Ji of BridgeBio

EP 211: Building hope for inherited blindness and deafness with Justin Porcano of Save Sight Now

EP 210: Live from ASHG: Breaking barriers in genomics with Heidi Rehm of the Broad Institute and Slavé Petrovski of AstraZeneca

EP 209: Reinventing Fabry disease treatment with Chris Hopkins of Glafabra Therapeutics

EP 208: Gene therapy at a crossroads: Successes, concerns, and the path forward

EP 207: Decoding Parkinson’s genetics on a global scale with Andy Singleton and Sonya Dumanis of GP2 and ASAP

EP 206: From caregiving to catalyzing FTD research with Wanda Smith of CureGRN

EP 205: From father to biotech founder: Building hope for children with ultra-rare diseases with Terry Pirovolakis of Elpida Therapeutics

EP 204: Bringing cardiovascular genetics and biobank discoveries into the clinic with Samuli Ripatti of the University of Helsinki

EP 203: Building the tools behind modern genomics with Jonathan Marchini of Regeneron

EP 202: Biotech at the intersection of science and politics with Max Bronstein of Aviva Strategies

EP 201: The gene therapy playbook: Successes, setbacks, and the path forward with Richard Wilson of Astellas

EP 200: From predictions to breakthroughs in genetics and biotech

EP 199: Functional genomics at scale: Using in vivo perturbations to study genetic risk variants in the brain with Xin Jin of Scripps Research Institute

EP 198: Reimagining clotting disorders: Patient voices and “unreasonable” leadership with Benny Sorenson of Hemab Therapeutics

EP 197: From biobanks to breakthroughs: Linking genomics to drug discovery with Heiko Runz of insitro

EP 196: A new vision for sequencing: In-sample multiomics and precision medicine with Molly He

EP 195: From junk to therapy: The untapped power of regulatory RNAs with David Bumcrot of CAMP4 Therapeutics

EP 194: Ontologies, diagnostics, and genomics for all with Melissa Haendel of UNC Chapel Hill

EP 193: Targeting autophagy to treat neurodegeneration with Frank Gentile of Casma Therapeutics

EP 192: From $88 to breakthroughs: Innovation in retinal gene therapy with Dr. Huma Qamar of Ocugen

EP 191: Uncovering hidden histories and health insights from the Mexican Biobank with Andres Moreno-Estrada of LANGEBIO

EP 190: Targeting regeneration to tackle Duchenne Muscular Dystrophy with Frank Gleeson of Satellos

EP 189: From genetic heritability in twins to gut health with Tim Spector of King’s College London and Zoe

EP 188: Cracking the code of autism through genetics with Daniel Geschwind of UCLA

EP 187: Rethinking germline gene editing and revolutionizing women’s fertility with Helen O’Neill

EP 186: Unpacking the science and myths around obesity and health with geneticist and author Giles Yeo

EP 185: From newborn screening to lifelong data in an evolving genomics landscape with Madhuri Hegde of Revvity

EP 184: Rethinking speed and scale in clinical genomics with Euan Ashley of Stanford University

EP 183: Rewriting the Rules for Ultra-Rare Diseases with Kent Rogers of EveryONE Medicines

EP 182: Demystifying genetic counseling with Matt Burgess

EP 181: Transforming frustration into breakthroughs in gene therapy with Salvador Rico of Encoded Therapeutics

EP 180: From a consulting project to a biotech start-up with Leeland Ekstrom of Nashville Bio

EP 179: Redefining rare disease realities with Sharon Terry of the Genetic Alliance

EP 178: Expanding the human proteome to facilitate drug discovery with John Lepore of ProFound Therapeutics

EP 177: The vision of Our Future Health with Raghib Ali

EP 176: Hunting rare kidney disease mutations with Anthony Bleyer of Wake Forest and Stan Kmoch of Charles University

EP 175: Pioneering treatment for stop codon disease using tRNA with Michelle Werner of Alltrna

EP 174: Decentralized science and reducing the cost of gene therapies with Jocelynn Pearl of the TAM Center

EP 173: Tackling genetic cardiomyopathy from the bed to the bench with Eric Adler of Lexeo Therapeutics and UCSD

EP 172: Racial health disparities in genetic testing and breast cancer treatment with Dr. Versha Pleasant of University of Michigan

EP 171: The past, present, and future of long-read sequencing with Jonathon Hill of Wasatch Biolabs

EP 170: Pan-European collaboration and dementia research with Angela Bradshaw, from Alzheimer Europe

EP 169: Common variants in rare neurological diseases with Hilary Martin of the Wellcome Sanger Institute

EP 168: A world-first in RNA medicines with Erik Ingelsson, Chief Scientific Officer at Wave Life Sciences

EP 167: Research Roundup with Dr. Veera: Wrapping up 2024 in four pioneering papers

EP 166: Developing targeted therapies for ALS with Eric Green from Trace Neuroscience, Maze Therapeutics, and Stanford University

EP 165: Harnessing CRISPR and RNA editing to transform healthcare with Dr. Ness Bermingham